"Frenova's MyReason initiative and unparalleled expertise in nephrology, combined with Azenta's state-of-the-art genomic sequencing and sample management solutions, represent essential cornerstones of ...
Dorde Krstic/Shutterstock.com. For more than a century, type 1 diabetes has meant one thing. a lifetime administering insulin ...Type 1 diabetes is an autoimmune condition that leads to complete loss of insulin production from the pancreas ... .
... the American Journal of Nephrology (AJN) highlighting the design and rationale of the Company's Phase 2 KOURAGE trial of lead candidate Auxora™ in acute kidney injury (AKI) with respiratory failure.
New York, USA - June 20, 2025 - Ace Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development.